- Home
- GRRR vs AQST Comparison
GRRR vs AQST Comparison
Compare GRRR & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRRR
- AQST
- Stock Information
- Founded
- GRRR 2001
- AQST 2004
- Country
- GRRR United Kingdom
- AQST United States
- Employees
- GRRR N/A
- AQST N/A
- Industry
- GRRR Computer Software: Prepackaged Software
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- GRRR Technology
- AQST Health Care
- Exchange
- GRRR Nasdaq
- AQST Nasdaq
- Market Cap
- GRRR 391.9M
- AQST 390.4M
- IPO Year
- GRRR N/A
- AQST 2018
- Fundamental
- Price
- GRRR $18.13
- AQST $5.05
- Analyst Decision
- GRRR Buy
- AQST Strong Buy
- Analyst Count
- GRRR 1
- AQST 7
- Target Price
- GRRR $18.00
- AQST $10.29
- AVG Volume (30 Days)
- GRRR 1.1M
- AQST 2.4M
- Earning Date
- GRRR 08-14-2025
- AQST 11-03-2025
- Dividend Yield
- GRRR N/A
- AQST N/A
- EPS Growth
- GRRR N/A
- AQST N/A
- EPS
- GRRR N/A
- AQST N/A
- Revenue
- GRRR $93,325,178.00
- AQST $44,132,000.00
- Revenue This Year
- GRRR $38.13
- AQST N/A
- Revenue Next Year
- GRRR $28.55
- AQST $38.71
- P/E Ratio
- GRRR N/A
- AQST N/A
- Revenue Growth
- GRRR 18.22
- AQST N/A
- 52 Week Low
- GRRR $3.16
- AQST $2.12
- 52 Week High
- GRRR $44.15
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- GRRR 55.12
- AQST 66.65
- Support Level
- GRRR $17.45
- AQST $4.75
- Resistance Level
- GRRR $18.63
- AQST $5.60
- Average True Range (ATR)
- GRRR 0.89
- AQST 0.29
- MACD
- GRRR 0.20
- AQST 0.09
- Stochastic Oscillator
- GRRR 82.58
- AQST 70.59
About GRRR Gorilla Technology Group Inc.
Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.